Cargando…
Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes
The ability to alter antigen specificity by T-cell receptor (TCR) or chimeric antigen receptor (CAR) gene transfer has facilitated personalized cellular immune therapies in cancer. Inversely, this approach can be harnessed in autoimmune settings to attenuate inflammation by redirecting the specifici...
Autores principales: | Yeh, Wen-I, Seay, Howard R., Newby, Brittney, Posgai, Amanda L., Moniz, Filipa Botelho, Michels, Aaron, Mathews, Clayton E., Bluestone, Jeffrey A., Brusko, Todd M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662552/ https://www.ncbi.nlm.nih.gov/pubmed/29123516 http://dx.doi.org/10.3389/fimmu.2017.01313 |
Ejemplares similares
-
Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8(+) T cells
por: Peters, Leeana D., et al.
Publicado: (2023) -
Avidity-Dependent Programming of Autoreactive T Cells in T1D
por: Durinovic-Belló, Ivana, et al.
Publicado: (2014) -
Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells
por: Choi, Seung-Chul, et al.
Publicado: (2018) -
High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?
por: Thomas, Ranjeny, et al.
Publicado: (2008) -
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
por: Brusko, Maigan A., et al.
Publicado: (2020)